+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Automated Compounding Devices Market by Type, Application, End User, Distribution Channel, Software Type, Workflow Type - Global Forecast to 2030- Product Image
Automated Compounding Devices Market by Type, Application, End User, Distribution Channel, Software Type, Workflow Type - Global Forecast to 2030- Product Image
Sale

Automated Compounding Devices Market by Type, Application, End User, Distribution Channel, Software Type, Workflow Type - Global Forecast to 2030

  • PDF Icon

    Report

  • 186 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5924780
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Automated Compounding Devices Market grew from USD 2.56 billion in 2024 to USD 2.84 billion in 2025. It is expected to continue growing at a CAGR of 10.59%, reaching USD 4.69 billion by 2030.

Pioneering the Future of Pharmaceutical Automation

Automated compounding devices have emerged as a cornerstone in modern pharmaceutical practice, redefining precision and safety in medication preparation. This executive summary outlines the transformative journey of these technologies, highlighting their role in minimizing human error and optimizing workflow efficiency. The rapid integration of robotics, advanced software algorithms, and real-time monitoring has elevated compounding from a manual art to a data-driven process, ensuring consistent quality and compliance across diverse healthcare settings.

As healthcare systems worldwide grapple with increasing demand for personalized therapies and stringent regulatory scrutiny, compounding automation stands at the forefront of operational innovation. This introduction frames the key themes explored in the report: technological advancements, regulatory influences, market segmentation, regional dynamics, and strategic recommendations. Through a clear lens, readers will gain a foundational understanding of how automated compounding devices are reshaping the pharmaceutical landscape and driving value for providers, payers, and patients alike.

Harnessing Digital and Robotic Synergies in Compounding

In recent years, the landscape of medication preparation has undergone a seismic shift driven by breakthroughs in mechatronics and digital integration. Traditional manual compounding, once prone to variation and bottlenecks, has given way to platforms that seamlessly blend robotics with cloud-based analytics. This evolution has not only enhanced throughput but also enabled remote monitoring and predictive maintenance, ensuring uninterrupted service delivery and robust safety protocols.

Concurrently, the convergence of artificial intelligence and machine learning has empowered compounding devices to adapt to new formulations with minimal downtime. Systems now leverage real-time feedback loops to adjust flow rates, detect anomalies, and verify dosing parameters automatically. These innovations have fostered a culture of continuous improvement, where iterative software updates deliver incremental gains in performance and regulatory compliance. As a result, healthcare providers can allocate resources more effectively, redirecting skilled personnel to clinical tasks that demand human expertise.

Adapting Supply Chains for Tariff-Driven Cost Pressures

Anticipated adjustments to tariffs in 2025 have already begun to influence procurement strategies and supply chain configurations for compounding devices. Manufacturers and distributors are proactively reassessing sourcing models to mitigate potential cost increases on imported components. This recalibration has accelerated the localization of critical hardware production and incentivized partnerships that secure preferential trade terms.

Moreover, the projected tariff structure has prompted device integrators to refine total cost of ownership models, emphasizing modular designs that allow for component standardization across geographies. By reducing reliance on bespoke parts subject to punitive duties, industry stakeholders safeguard margin integrity while maintaining technological agility. These measures underscore a collective commitment to resilience in the face of evolving trade policies, ensuring that healthcare institutions continue to access state-of-the-art compounding solutions without compromise.

Decoding Market Segments to Match Clinical Needs

An in-depth segmentation analysis reveals that device format influences not only operational performance but also integration complexity. Peristaltic pumps, piston driven mechanisms, and volumetric systems each bring distinct accuracy profiles, making the choice of type critical for tailored therapy preparation. Application domains further refine market dynamics, with analgesia fulfilling acute pain protocols, chemotherapy addressing general oncology and targeted therapy regimens, and parenteral nutrition configured for central venous and peripheral venous delivery. End-user environments vary widely, spanning compounding pharmacies, home healthcare providers, hospital pharmacies in large and small institutions, and retail pharmacies, each imposing unique space, staffing, and throughput requirements. Distribution models range from direct sales arrangements to partnerships with national and regional distributors, as well as online platforms that streamline procurement. Software architectures divide into integrated suites that tie directly into electronic health records and standalone applications that offer plug-and-play functionality. Workflow modalities oscillate between batch operations suited to high-volume settings and continuous processes optimized for just-in-time medication preparation. This nuanced view of segmentation underscores the importance of aligning device capabilities with clinical objectives and organizational constraints.

Navigating Regional Dynamics to Optimize Deployment

Regional dynamics exert a pronounced influence on adoption rates and technology evolution. In the Americas, established regulatory frameworks and large hospital networks have catalyzed swift uptake of advanced compounding platforms, supported by robust reimbursement mechanisms and strong capital investment climates. Transitioning to Europe, Middle East & Africa, varied healthcare infrastructures and evolving compliance standards shape a diverse market environment where mid-sized hospital systems often lead pilot programs for automation. Manufacturers tailor solutions to address complex regulatory mosaics and logistical challenges, particularly in emerging economies.

Shifting focus to Asia-Pacific, rapid economic expansion and concerted efforts to upgrade healthcare delivery have driven significant investment in compounding automation. National initiatives promoting patient safety and drug quality have accelerated procurement cycles, with metropolitan centers adopting centralized compounding facilities that service broader regional catchments. Collectively, these regional insights illustrate how local policies, infrastructure maturity, and economic priorities converge to define distinct adoption trajectories.

Spotlight on Strategic Innovation and Service Leadership

Leading players have demonstrated a clear focus on software-driven innovation, forging partnerships with life science firms and academic institutions to refine dosing algorithms and expand therapy libraries. Strategic acquisitions have bolstered product portfolios, enabling firms to offer turnkey solutions that integrate hardware, software, and ongoing maintenance services. Investment in service networks has emerged as a differentiator, with rapid response teams and remote diagnostics capabilities ensuring minimal disruption to clinical operations.

Additionally, key companies are leveraging data analytics to create value-added offerings, translating aggregated usage insights into predictive maintenance programs and workflow optimization consulting. This shift from transactional sales to outcome-based engagements reflects a broader industry trend toward service-oriented business models. As competition intensifies, the ability to demonstrate measurable improvements in safety, efficiency, and cost containment will separate market leaders from followers.

Strategies to Reinforce Agility and Resilience

Industry leaders should prioritize modularity in device design to accommodate evolving therapy protocols and regulatory requirements. By adopting plug-and-play architectures, organizations can future-proof investments and reduce time to market for new formulations. Cultivating cross-functional teams that bridge engineering, clinical, and data science expertise will accelerate innovation pipelines and ensure that product roadmaps align with real-world customer needs.

In parallel, forging strategic alliances across the supply chain can mitigate tariff exposures and reinforce component availability. Engaging in co-development initiatives with academic centers and contract manufacturing partners will strengthen the resilience of the ecosystem. Finally, embedding robust cybersecurity measures and adhering to emerging interoperability standards will build trust among healthcare providers and safeguard patient data.

Robust Approach Underpinning In-Depth Insights

This report synthesizes qualitative interviews with senior executives, clinical end-users, and regulatory experts, alongside a comprehensive review of public filings, patent databases, and scientific literature. Primary research sessions were conducted to capture firsthand perspectives on technology performance, implementation challenges, and unmet market needs. Secondary research encompassed analysis of policy documents, industry association publications, and competitive intelligence platforms to triangulate data points and ensure consistency.

Rigorous validation processes included cross-referencing supplier disclosures, end-user feedback, and third-party audit reports. The methodological framework emphasizes transparency and reproducibility, with clear documentation of data sources, interview protocols, and analytical techniques. By integrating multiple research modalities, the report delivers a holistic perspective on market dynamics and strategic imperatives.

Converging Trends Crafting Tomorrow’s Compounding Ecosystem

Automated compounding devices are poised to redefine medication preparation workflows, delivering enhanced precision, safety, and operational efficiency. As tariff landscapes shift and regional dynamics evolve, stakeholders who embrace flexible segmentation strategies and invest in service-centric business models will thrive. The convergence of robotics, data analytics, and regulatory compliance underscores a future where compounding technology becomes an integral enabler of personalized medicine.

This executive summary has traced the critical trends shaping the market, from supply chain adaptations to segmentation nuances and company strategies. It lays the groundwork for informed decision-making, offering a strategic overview that bridges technical detail with actionable insight. Ultimately, those who harness the full spectrum of automation capabilities will secure a competitive edge and drive meaningful improvements in patient care.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Type
    • Peristaltic
    • Piston Driven
    • Volumetric
  • Application
    • Analgesia
    • Chemotherapy
      • General Oncology
      • Targeted Therapy
    • Parenteral Nutrition
      • Central Venous
      • Peripheral Venous
  • End User
    • Compounding Pharmacy
    • Home Healthcare
    • Hospital Pharmacy
      • Large Hospital
      • Small Hospital
    • Retail Pharmacy
  • Distribution Channel
    • Direct Sales
    • Distributors
      • National Distributors
      • Regional Distributors
    • Online Sales
  • Software Type
    • Integrated
    • Standalone
  • Workflow Type
    • Batch
    • Continuous
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Baxter International Inc.
  • Fresenius Kabi AG
  • B. Braun Melsungen AG
  • ICU Medical, Inc.
  • Omnicell, Inc.
  • Ivenix, Inc.
  • Qcore Medical, Inc.
  • Telstar S.A.
  • Swisslog AG
  • Capsa Healthcare, Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Automated Compounding Devices Market, by Type
8.1. Introduction
8.2. Peristaltic
8.3. Piston Driven
8.4. Volumetric
9. Automated Compounding Devices Market, by Application
9.1. Introduction
9.2. Analgesia
9.3. Chemotherapy
9.3.1. General Oncology
9.3.2. Targeted Therapy
9.4. Parenteral Nutrition
9.4.1. Central Venous
9.4.2. Peripheral Venous
10. Automated Compounding Devices Market, by End User
10.1. Introduction
10.2. Compounding Pharmacy
10.3. Home Healthcare
10.4. Hospital Pharmacy
10.4.1. Large Hospital
10.4.2. Small Hospital
10.5. Retail Pharmacy
11. Automated Compounding Devices Market, by Distribution Channel
11.1. Introduction
11.2. Direct Sales
11.3. Distributors
11.3.1. National Distributors
11.3.2. Regional Distributors
11.4. Online Sales
12. Automated Compounding Devices Market, by Software Type
12.1. Introduction
12.2. Integrated
12.3. Standalone
13. Automated Compounding Devices Market, by Workflow Type
13.1. Introduction
13.2. Batch
13.3. Continuous
14. Americas Automated Compounding Devices Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Automated Compounding Devices Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Automated Compounding Devices Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Baxter International Inc.
17.3.2. Fresenius Kabi AG
17.3.3. B. Braun Melsungen AG
17.3.4. ICU Medical, Inc.
17.3.5. Omnicell, Inc.
17.3.6. Ivenix, Inc.
17.3.7. Qcore Medical, Inc.
17.3.8. Telstar S.A.
17.3.9. Swisslog AG
17.3.10. Capsa Healthcare, Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. AUTOMATED COMPOUNDING DEVICES MARKET MULTI-CURRENCY
FIGURE 2. AUTOMATED COMPOUNDING DEVICES MARKET MULTI-LANGUAGE
FIGURE 3. AUTOMATED COMPOUNDING DEVICES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY WORKFLOW TYPE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY WORKFLOW TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. AUTOMATED COMPOUNDING DEVICES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. AUTOMATED COMPOUNDING DEVICES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. AUTOMATED COMPOUNDING DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PERISTALTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PISTON DRIVEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY VOLUMETRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY ANALGESIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY GENERAL ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CENTRAL VENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PERIPHERAL VENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COMPOUNDING PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY LARGE HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SMALL HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE TYPE, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY INTEGRATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY STANDALONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY WORKFLOW TYPE, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY BATCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CONTINUOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE TYPE, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY WORKFLOW TYPE, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE TYPE, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY WORKFLOW TYPE, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 63. CANADA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 64. CANADA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. CANADA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 66. CANADA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2030 (USD MILLION)
TABLE 67. CANADA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. CANADA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 69. CANADA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 70. CANADA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 71. CANADA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE TYPE, 2018-2030 (USD MILLION)
TABLE 72. CANADA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY WORKFLOW TYPE, 2018-2030 (USD MILLION)
TABLE 73. MEXICO AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 74. MEXICO AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. MEXICO AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 76. MEXICO AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2030 (USD MILLION)
TABLE 77. MEXICO AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 78. MEXICO AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 79. MEXICO AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 80. MEXICO AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 81. MEXICO AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE TYPE, 2018-2030 (USD MILLION)
TABLE 82. MEXICO AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY WORKFLOW TYPE, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE TYPE, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY WORKFLOW TYPE, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE TYPE, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY WORKFLOW TYPE, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE TYPE, 2018-2030 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY WORKFLOW TYPE, 2018-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 114. UNITED KINGDOM AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 115. UNITED KINGDOM AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. UNITED KINGDOM AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 117. UNITED KINGDOM AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2030 (USD MILLION)
TABLE 118. UNITED KINGDOM AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 119. UNITED KINGDOM AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 120. UNITED KINGDOM AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 121. UNITED KINGDOM AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 122. UNITED KINGDOM AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE TYPE, 2018-2030 (USD MILLION)
TABLE 123. UNITED KINGDOM AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY WORKFLOW TYPE, 2018-2030 (USD MILLION)
TABLE 124. GERMANY AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 125. GERMANY AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. GERMANY AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 127. GERMANY AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2030 (USD MILLION)
TABLE 128. GERMANY AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. GERMANY AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 130. GERMANY AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 131. GERMANY AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 132. GERMANY AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE TYPE, 2018-2030 (USD MILLION)
TABLE 133. GERMANY AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY WORKFLOW TYPE, 2018-2030 (USD MILLION)
TABLE 134. FRANCE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 135. FRANCE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. FRANCE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 137. FRANCE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2030 (USD MILLION)
TABLE 138. FRANCE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 139. FRANCE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 140. FRANCE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 141. FRANCE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 142. FRANCE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE TYPE, 2018-2030 (USD MILLION)
TABLE 143. FRANCE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY WORKFLOW TYPE, 2018-2030 (USD MILLION)
TABLE 144. RUSSIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 145. RUSSIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. RUSSIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 147. RUSSIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2030 (USD MILLION)
TABLE 148. RUSSIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 149. RUSSIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 150. RUSSIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 151. RUSSIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE TYPE, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY WORKFLOW TYPE, 2018-2030 (USD MILLION)
TABLE 154. ITALY AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 155. ITALY AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 156. ITALY AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 157. ITALY AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2030 (USD MILLION)
TABLE 158. ITALY AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 159. ITALY AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 160. ITALY AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 161. ITALY AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 162. ITALY AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE TYPE, 2018-2030 (USD MILLION)
TABLE 163. ITALY AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY WORKFLOW TYPE, 2018-2030 (USD MILLION)
TABLE 164. SPAIN AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 165. SPAIN AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. SPAIN AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 167. SPAIN AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2030 (USD MILLION)
TABLE 168. SPAIN AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 169. SPAIN AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 170. SPAIN AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 171. SPAIN AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 172. SPAIN AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE TYPE, 2018-2030 (USD MILLION)
TABLE 173. SPAIN AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY WORKFLOW TYPE, 2018-2030 (USD MILLION)
TABLE 174. UNITED ARAB EMIRATES AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 175. UNITED ARAB EMIRATES AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 176. UNITED ARAB EMIRATES AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 177. UNITED ARAB EMIRATES AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2030 (USD MILLION)
TABLE 178. UNITED ARAB EMIRATES AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 179. UNITED ARAB EMIRATES AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE TYPE, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY WORKFLOW TYPE, 2018-2030 (USD MILLION)
TABLE 184. SAUDI ARABIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 185. SAUDI ARABIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 186. SAUDI ARABIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 187. SAUDI ARABIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2030 (USD MILLION)
TABLE 188. SAUDI ARABIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 189. SAUDI ARABIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 190. SAUDI ARABIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 191. SAUDI ARABIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 192. SAUDI ARABIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE TYPE, 2018-2030 (USD MILLION)
TABLE 193. SAUDI ARABIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY WORKFLOW TYPE, 2018-2030 (USD MILLION)
TABLE 194. SOUTH AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 195. SOUTH AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 196. SOUTH AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 197. SOUTH AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2030 (USD MILLION)
TABLE 198. SOUTH AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE TYPE, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY WORKFLOW TYPE, 2018-2030 (USD MILLION)
TABLE 204. DENMARK AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 205. DENMARK AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 206. DENMARK AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 207. DENMARK AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2030 (USD MILLION)
TABLE 208. DENMARK AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 209. DENMARK AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 210. DENMARK AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 211. DENMARK AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 212. DENMARK AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE TYPE, 2018-2030 (USD MILLION)
TABLE 213. DENMARK AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY WORKFLOW TYPE, 2018-2030 (USD MILLION)
TABLE 214. NETHERLANDS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 215. NETHERLANDS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 216. NETHERLANDS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 217. NETHERLANDS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2030 (USD MILLION)
TABLE 218. NETHERLANDS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 219. NETHERLANDS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 220. NETHERLANDS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 221. NETHERLANDS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 222. NETHERLANDS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE TYPE, 2018-2030 (USD MILLION)
TABLE 223. NETHERLANDS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY WORKFLOW TYPE, 2018-2030 (USD MILLION)
TABLE 224. QATAR AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 225. QATAR AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 226. QATAR AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 227. QATAR AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2030 (USD MILLION)
TABLE 228. QATAR AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 229. QATAR AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 230. QATAR AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 231. QATAR AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 232. QATAR AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE TYPE, 2018-2030 (USD MILLION)
TABLE 233. QATAR AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY WORKFLOW TYPE, 2018-2030 (USD MILLION)
TABLE 234. FINLAND AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 235. FINLAND AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 236. FINLAND AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 237. FINLAND AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2030 (USD MILLION)
TABLE 238. FINLAND AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 239. FINLAND AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 240. FINLAND AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 241. FINLAND AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 242. FINLAND AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE TYPE, 2018-2030 (USD MILLION)
TABLE 243. FINLAND AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY WORKFLOW TYPE, 2018-2030 (USD MILLION)
TABLE 244. SWEDEN AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 245. SWEDEN AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 246. SWEDEN AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 247. SWEDEN AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2030 (USD MILLION)
TABLE 248. SWEDEN AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 249. SWEDEN AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 250. SWEDEN AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 251. SWEDEN AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 252. SWEDEN AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE TYPE, 2018-2030 (USD MILLION)
TABLE 253. SWEDEN AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY WORKFLOW TYPE, 2018-2030 (USD MILLION)
TABLE 254. NIGERIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 255. NIGERIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 256. NIGERIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 257. NIGERIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2030 (USD MILLION)
TABLE 258. NIGERIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 259. NIGERIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 260. NIGERIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 261. NIGERIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 262. NIGERIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE TYPE, 2018-2030 (USD MILLION)
TABLE 263. NIGERIA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY WORKFLOW TYPE, 2018-2030 (USD MILLION)
TABLE 264. EGYPT AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 265. EGYPT AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 266. EGYPT AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 267. EGYPT AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2030 (USD MILLION)
TABLE 268. EGYPT AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 269. EGYPT AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 270. EGYPT AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 271. EGYPT AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 272. EGYPT AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE TYPE, 2018-2030 (USD MILLION)
TABLE 273. EGYPT AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY WORKFLOW TYPE, 2018-2030 (USD MILLION)
TABLE 274. TURKEY AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 275. TURKEY AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 276. TURKEY AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 277. TURKEY AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2030 (USD MILLION)
TABLE 278. TURKEY AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 279. TURKEY AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 280. TURKEY AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 281. TURKEY AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 282. TURKEY AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE TYPE, 2018-2030 (USD MILLION)
TABLE 283. TURKEY AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY WORKFLOW TYPE, 2018-2030 (USD MILLION)
TABLE 284. ISRAEL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 285. ISRAEL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 286. ISRAEL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 287. ISRAEL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2030 (USD MILLION)
TABLE 288. ISRAEL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 289. ISRAEL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 290. ISRAEL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 291. ISRAEL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 292. ISRAEL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE TYPE, 2018-2030 (USD MILLION)
TABLE 293. ISRAEL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY WORKFLOW TYPE, 2018-2030 (USD MILLION)
TABLE 294. NORWAY AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 295. NORWAY AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 296. NORWAY AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 297. NORWAY AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2030 (USD MILLION)
TABLE 298. NORWAY AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 299. NORWAY AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 300. NORWAY AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 301. NORWAY AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 302. NORWAY AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE TYPE, 2018-2030 (USD MILLION)
TABLE 303. NORWAY AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY WORKFLOW TYPE, 2018-2030 (USD MILLION)
TABLE 304. POLAND AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 305. POLAND AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 306. POLAND AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 307. POLAND AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2030 (USD MILLION)
TABLE 308. POLAND AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 309. POLAND AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 310. POLAND AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 311. PO

Companies Mentioned

The companies profiled in this Automated Compounding Devices market report include:
  • Baxter International Inc.
  • Fresenius Kabi AG
  • B. Braun Melsungen AG
  • ICU Medical, Inc.
  • Omnicell, Inc.
  • Ivenix, Inc.
  • Qcore Medical, Inc.
  • Telstar S.A.
  • Swisslog AG
  • Capsa Healthcare, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages186
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2.84 Billion
Forecasted Market Value ( USD ) by 2030 $ 4.69 Billion
Compound Annual Growth Rate10.5%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Automated Compounding Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Automated Compounding Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Automated Compounding Devices Market Report 2025 - Product Image

Automated Compounding Devices Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Pharmacy Automation Devices Market Report 2025 - Product Image

Pharmacy Automation Devices Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Pharmacy Market Size, Share & Trends Analysis Report by Product (Prescription, OTC), Type (Retail Pharmacy, ePharmacy), Region (North America, Europe), and Segment Forecasts, 2024-2030 - Product Image

Pharmacy Market Size, Share & Trends Analysis Report by Product (Prescription, OTC), Type (Retail Pharmacy, ePharmacy), Region (North America, Europe), and Segment Forecasts, 2024-2030

  • Report
  • 145 Pages
  • Global
From
U.S. Compounding Pharmacies Market Size, Share, & Trends Analysis Report By Type (503A, 503B), By Therapeutic Area, By Age Cohort, Compounding Type, By Sterility, And Segment Forecasts, 2024 - 2030 - Product Image

U.S. Compounding Pharmacies Market Size, Share, & Trends Analysis Report By Type (503A, 503B), By Therapeutic Area, By Age Cohort, Compounding Type, By Sterility, And Segment Forecasts, 2024 - 2030

  • Report
  • 100 Pages
  • United States
From

About the Automated Compounding Market

The Automated Compounding market within the Healthcare Services sector is a rapidly growing industry. It is focused on the development of automated systems for the preparation of medications for patients. Automated compounding systems are designed to reduce the risk of errors in the preparation of medications, as well as to increase the efficiency of the process. Automated compounding systems are used in a variety of healthcare settings, including hospitals, pharmacies, and long-term care facilities. The Automated Compounding market is driven by the need for improved safety and accuracy in the preparation of medications. Additionally, the increasing demand for cost-effective and efficient medication preparation is driving the growth of the market. Some of the major companies in the Automated Compounding market include Baxter International, Becton Dickinson, CareFusion, Cerner Corporation, and Omnicell. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.